[1]BioorganicandMedicinalChemistry,2010,vol.18,#18,p.6785-6795
[2]EuropeanJournalofOrganicChemistry,2009,#1,p.38-42
[1]EuropeanJournalofOrganicChemistry,2009,#1,p.38-42
Title: Roles of glycogen synthase kinase 3 in Alzheimer's disease.
Journal: Current Alzheimer research 20120901
Title: Selectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer's disease.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20120523
Title: Novel indolylmaleimide acts as GSK-3beta inhibitor in human neural progenitor cells.
Journal: Bioorganic & medicinal chemistry 20100915
Title: Mammalian Ryk is a Wnt coreceptor required for stimulation of neurite outgrowth.
Journal: Cell 20041001
Title: Increased neuronal production, enlarged forebrains and cytoarchitectural distortions in beta-catenin overexpressing transgenic mice.
Journal: Cerebral cortex (New York, N.Y. : 1991) 20030601
Title: The status of Wnt signalling regulates neural and epidermal fates in the chick embryo.
Journal: Nature 20010517
Title: Axonal remodeling and synaptic differentiation in the cerebellum is regulated by WNT-7a signaling.
Journal: Cell 20000303
Title: Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes.
Journal: Diabetes 20000201
Title: Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice.
Journal: Diabetes 19990801
Title: Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity.
Journal: Proceedings of the National Academy of Sciences of the United States of America 19930815
Title: Schmole AC, et al. Novel indolylmaleimide acts as GSK-3beta inhibitor in human neural progenitor cells. Bioorg Med Chem. 2010 Sep 15;18(18):6785-95.
